PAHC vs. SYK: Which Stock Should Value Investors Buy Now?
Stryker launches TPX HD® power tool, supporting demanding orthopaedic procedures
Is Stryker Stock Underperforming the S&P 500?
Is Stryker (SYK) Reframing Its Innovation Edge With Pangea And Cybersecurity Investments?
Director Of Stryker Sold $96.79M In Stock
Assessing Stryker (SYK) Valuation After Mixed Q1 Results And Cyberattack Concerns
Is Stryker (SYK) One of the Best Medical Technology Stocks to Buy Right Now Despite a Cyberattack?
Stryker Launches Pangea Plating System in Europe for Fracture Fixation
Stryker: Reaching Interesting Levels
Barclays Cuts PT on Stryker Corporation (SYK), Calls Q1 Results Mixed
Stryker Launches Pangea Plating System and Completes First Case in Europe
Stryker Expands Peripheral Vascular Reach With Amplitude Deal And Undervalued Shares
Stryker’s chief accounting officer to retire
Podcast: Supply chains, obesity drugs, and patents dominate Q1 earnings trends
Is Wall Street Bullish or Bearish on Stryker Corporation Stock?
Stryker: Investors May Have Overreacted To Q1 Weakness
1 Oversold Stock Set for a Comeback and 2 That Underwhelm
BioStar Capital-Backed Amplitude Vascular Systems’ $835M Acquisition by Stryker Reflects Strength of Michigan’s Medtech Ecosystem
PAHC or SYK: Which Is the Better Value Stock Right Now?
Stryker Corp (NYSE:SYK) Passes the Caviar Cruise Quality Screen
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.